SELE and cancer: Therefore, hindering cancer cell migratory abilities by blocking E-selectin and/or their ligands is believed to hamper cancer cell extravasation and formation of new metastatic lesions in distant organs, all of which also has been scrutinized by specifically targeting E-selectin [7,15,19,22,29,62,63].